FY2025 EPS Estimates for CureVac Raised by Leerink Partnrs
CureVac (NASDAQ:CVAC – Free Report) – Equities research analysts at Leerink Partnrs raised their FY2025 earnings per share (EPS) estimates for CureVac in a research note issued to investors on Tuesday, May 20th. Leerink Partnrs analyst M. Foroohar now anticipates that the company will post earnings of ($0.68) per share for the year, up from […]
